** Shares of digital therapeutics company Better Therapeutics fall as much as 84% to record low of 3 cents, last down 81%
** Co says it will explore strategic alternatives including winding down
** Co also says it is terminating its employees
** Decision was made at a special board meeting on Wednesday - BTTX
** Co has voluntarily requested delisting from Nasdaq
** BTTX intends to file Form 15 with the U.S. Securities and Exchange Commission to suspend its reporting obligations
** Including session moves, stock has fallen 96.6% in the last 12 months
(Reporting by Sneha S K in Bengaluru)
((Sneha.SK@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments